HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Charles C. Canver Charles A.S. Marrin Stephen K. Plume William C. Nugent Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Canver, C. C. Articles by Nugent, W. C. Search for Related Content PubMed PubMed Citation Articles by Canver, C. C. Articles by Nugent, W. C.

Ann Thorac Surg 1993;55:1202-1204
© 1993 The Society of Thoracic Surgeons

---

Articles

Should a patient with a treated cancer be offered an open heart operation?

Section of Cardiothoracic Surgery, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire USA

Accepted for publication September 4, 1992.

^_* Address reprint requests to Dr Canver, Section of Cardiothoracic Surgery, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon NH 03756-0001.

The unknown but presumably reduced life expectancy of patients with malignant neoplasms may dissuade surgeons from performing necessary coronary and valvular heart operations. There is also concern for recrudescence of cancer as a result of an impaired immune system after cardiopulmonary bypass. We analyzed the records of 2,190 patients who underwent cardiac operations requiring extracorporeal circulation between 1988 and 1990. Of these, 46 patients had previously been treated for malignancy other than nonmelanoma skin cancer. Open heart operations were performed in patients with cardiac symptoms only in the absence of tumor recurrence. Tumor staging indicated reduced life expectancy in all patients. Thirty-eight patients (82.7%) had myocardial revascularization; 8 patients (17.3%) underwent valve operations. Postoperatively, all but 2 patients were free from complications. In-hospital mortality was 4.3% ([equation]). One patient died of cardiogenic shock after combined aortic and mitral valve replacement; the second patient succumbed to pulmonary embolism after reoperative coronary artery bypass grafting. Actuarial survival at 3 years was 96%, and all patients reported a satisfactory quality of life. This experience suggests that cardiac operations in selected patients with previously treated cancer are safe and offer clinical improvement at a reasonable operative risk.

This article has been cited by other articles:

				W. Dyszkiewicz, M. Jemielity, C. Piwkowski, M. Kasprzyk, B. Perek, L. Gasiorowski, and E. Kaczmarek The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease Eur J Cardiothorac Surg, September 1, 2008; 34(3): 531 - 535. [Abstract] [Full Text] [PDF]

				E. Erez, S. Eldar, E. Sharoni, D. Abramov, A. Sulkes, and B. A. Vidne Coronary artery operation in patients after breast cancer therapy Ann. Thorac. Surg., October 1, 1998; 66(4): 1312 - 1317. [Abstract] [Full Text] [PDF]